title: Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.
abstract: OBJECTIVE
  The purpose of this study was to determine the relationship between Rho-associated kinase (ROCK) activity and aortic stiffness in humans.
  
  
  BACKGROUND
  Epidemiologic studies have shown that there is a relationship between aortic stiffness and cardiovascular complications. Recent evidence suggests that ROCK plays an important role in the process of atherosclerosis.
  
  
  METHODS
  We evaluated the forearm blood flow (FBF) response to sodium nitroprusside (SNP), a nitric oxide donor, acetylcholine (ACh), an endothelium-dependent vasodilator, and fasudil, a specific ROCK inhibitor, in 51 healthy male subjects (mean age 45.6 +/- 3.0 years). The FBF was measured by using a strain-gauge plethysmography. Carotid-femoral pulse wave velocity (cf-PWV) was measured to assess the aortic stiffness using a pulse wave velocimeter.
  
  
  RESULTS
  Intra-arterial infusion of SNP alone, ACh alone, or fasudil alone and after co-infusion of N(G)-monomethyl-L-arginine (L-NMMA), a nitric-oxide synthase inhibitor, significantly increased FBF in a dose-dependent manner (p < 0.01). Multivariate analysis showed that age and number of pack-years smoked were independent predictors of ROCK activity before or after co-infusion of L-NMMA (p < 0.01) and that age and ROCK activity before or after co-infusion of L-NMMA were independent predictors of cf-PWV (p < 0.01). The concentration of serum malondialdehyde-modified low-density lipoprotein, an index of oxidative stress, was significantly correlated with ROCK activity before and after co-infusion of L-NMMA and cf-PWV (p < 0.01).
  
  
  CONCLUSIONS
  These findings suggest that aging and accumulating smoking habit, which might induce excessive oxidative stress, are involved in ROCK activity in the vasculature, leading to an increase in aortic stiffness in humans.
authors.affiliation: Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
authors.forename: Kensuke
authors.initials: K
authors.lastname: Noma
authors.forename: Chikara
authors.initials: C
authors.lastname: Goto
authors.forename: Kenji
authors.initials: K
authors.lastname: Nishioka
authors.forename: Daisuke
authors.initials: D
authors.lastname: Jitsuiki
authors.forename: Takashi
authors.initials: T
authors.lastname: Umemura
authors.forename: Keiko
authors.initials: K
authors.lastname: Ueda
authors.forename: Masashi
authors.initials: M
authors.lastname: Kimura
authors.forename: Keigo
authors.initials: K
authors.lastname: Nakagawa
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Oshima
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Chayama
authors.forename: Masao
authors.initials: M
authors.lastname: Yoshizumi
authors.forename: James K
authors.initials: JK
authors.lastname: Liao
authors.forename: Yukihito
authors.initials: Y
authors.lastname: Higashi
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives / Q000494:pharmacology; D000109:Acetylcholine / Q000494:pharmacology; D000328:Adult; D001018:Aortic Diseases / Q000209:etiology* / Q000503:physiopathology; D050197:Atherosclerosis / Q000209:etiology* / Q000503:physiopathology; D005542:Forearm / Q000098:blood supply; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D020030:Nitric Oxide Donors / Q000494:pharmacology; D009599:Nitroprusside / Q000494:pharmacology; D018384:Oxidative Stress / Q000187:drug effects*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*; D012039:Regional Blood Flow / Q000187:drug effects*; D054460:rho-Associated Kinases
chemical_list: D047908:Intracellular Signaling Peptides and Proteins; D020030:Nitric Oxide Donors; D047428:Protein Kinase Inhibitors; D009599:Nitroprusside; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases; D000109:Acetylcholine; C049347:fasudil